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Abstract
Autosomal recessive primary microcephaly (MCPH) is a neurodevelopmental disorder that is characterised by
microcephaly present at birth and non-progressive mental retardation. Microcephaly is the outcome of a smaller
but architecturally normal brain; the cerebral cortex exhibits a significant decrease in size. MCPH is a neurogenic
mitotic disorder, though affected patients demonstrate normal neuronal migration, neuronal apoptosis and neural
function. Twelve MCPH loci (MCPH1-MCPH12) have been mapped to date from various populations around the
world and contain the following genes: Microcephalin, WDR62, CDK5RAP2, CASC5, ASPM, CENPJ, STIL, CEP135, CEP152,
ZNF335, PHC1 and CDK6. It is predicted that MCPH gene mutations may lead to the disease phenotype due to a
disturbed mitotic spindle orientation, premature chromosomal condensation, signalling response as a result of
damaged DNA, microtubule dynamics, transcriptional control or a few other hidden centrosomal mechanisms that
can regulate the number of neurons produced by neuronal precursor cells. Additional findings have further
elucidated the microcephaly aetiology and pathophysiology, which has informed the clinical management of
families suffering from MCPH. The provision of molecular diagnosis and genetic counselling may help to decrease
the frequency of this disorder.
Introduction
In this review article, we discuss the clinical manifesta-
tions of autosomal recessive primary microcephaly
(MCPH), its incidence, and molecular genetics, including
a comprehensive review of the twelve known mapped
loci (MCPH1-MCPH12). Further, we review the corre-
sponding genes and the proteins encoded by these genes,
their possible role in the developing brain and reported
mutations of these genes. In addition, the potential for
these genes to perform various cognitive roles during
human brain evolutionary processes is discussed.
Clinical features of MCPH
Microcephaly is characterised by a reduced occipitofrontal
circumference (OFC) of the head that is at least 4 standard
deviations (SD) and is caused by congenital insufficiency
during fetal brain development, which chiefly affects the
cerebral cortex. The current clinical definition of MCPH is
as follows: A: a head circumference (HC) of at least 4 SD
below the age- and sex-matched means [1]; B: intellectual
impairment that is not related to a neurological finding,
such as spasticity or progressive cognitive decline [1]; and
C: most MCPH patients are of a normal height, weight,
and appearance and have normal chromosome analysis
and brain scan results [2,3]. The only exception of this is
observed in patients with mutations in the microcephalin
gene who have a clinically defined short stature and
abnormal chromosome analysis results [4-6]. Microce-
phaly in MCPH is primary, is evident by the 32nd week of
gestation, can be observed at the time of birth and is
non-progressive [7,8]. HC or OFC is the most common
diagnostic tool used for MCPH. Based on the findings of
several studies conducted on more than 200 families
worldwide, it is believed that the specific physical
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appearance of patients linked to each MCPH locus is
indistinguishable [9-12]. Additionally, the chromosomal
analysis for most MCPH patients was reportedly normal
[9]. However, recent studies supported by modern neuro-
diagnostic modalities, such as computed tomography (CT)
scan and magnetic resonance imaging (MRI), have signifi-
cantly increased our knowledge regarding the discernible
clinical presentations of MCPH and have expanded the
definition of MCPH based on phenotype [7,13,14].
Molecular Genetics of MCPH
MCPH Incidence
Primary microcephaly is present at birth and is a static
developmental anomaly, whereas secondary microce-
phaly develops postnatally and is a progressive neurode-
generative condition. Primary microcephaly is very rare,
and the rate of incidence is estimated to be 1 in 30,000
in Japan [15] and 1 in 250,000 in Holland [16]. The inci-
dence is increased up to 1 in 10,000 in regions where
marriages between cousins are common [1,6]. The birth
incidence of primary microcephaly differs from 1.3 to
150/100,000, depending on the population type and
consanguineous populations [17].
MCPH Inheritance
MCPH is inherited in an autosomal recessive pattern in
which both copies of the gene in each cell have mutations.
Individuals with MCPH inherit one copy of the mutated
gene from each parent, but the parents typically do not
demonstrate any signs or symptoms of the condition [18].
Genes in MCPH
MCPH is a neurogenic mitotic disorder that does not occur
due to abnormal neuronal migration or neural apoptosis.
Rather, it develops because all of the identified MCPH
genes are expressed in the neuroepithelium; the phenotypic
features and brain scans of MCPH patients reveal a smaller
than average brain size. Brain size during birth is deter-
mined by both the proliferation rate and cell death rate
during neurogenesis. The majority of neurons originate
from neural progenitors, which are the predominant cells
of the neuroepithelium (NE) lining the brain ventricles [1].
The precise mitotic activity of neuronal progenitor cells
was first described in fly neuroblasts: symmetrical cell divi-
sions with mitotic spindles oriented in the neuroepithelium
plane produce two neuronal progenitor cells, whereas
asymmetric cell division occurs when the mitotic spindles
are perpendicularly oriented toward the neuroepithelium
and results in one postmitotic neuron and one progenitor
cell [1]. Because the timing of these divisions during devel-
opment is critical for the final number of neurons, any
change in its regulation could lead to cortical disorders,
such as microcephaly [19]. MCPH exhibits genetic hetero-
geneity, and to date, twelve loci (MCPH1-MCPH12) have
been associated with this condition [20]. A comprehensive
review is outlined below of the twelve MCPH genes that
carry mutations, their possible functions in causing the
disease (Table 1), various mutations in people of different
ethnic backgrounds (Table 2) and animal model studies
(Table 3) of the MCPH genes.
1- Microcephalin (MCPH1)
MCPH1 encodes the BRCT (BRCA1 C-terminus)
domain-containing protein microcephalin; microcepha-
lin contains three BRCT domains, which are evolutiona-
rily conserved phospho-peptide-interacting amino acid
tandem repeat domains and are significant in cell cycle
control. MCPH1 is characterised by a congenital
decrease in brain size, especially in the cerebral cortex.
The microcephalin gene is localised on chromosome
8p23, is composed of 14 exons and 835 amino acids,
and has a genome size of 241,905 bp, with three already
known isoforms and an 8,032 bp open reading frame
[17,21]. The first documented MCPH1 gene mutation
was observed in Pakistani families [21]; additionally, a
large deletion mutation covering the first 6 exons of the
microcephalin gene was reported in an Iranian family
that exhibited autosomal recessive mental retardation
and mild microcephaly [22]. An observed missense
mutation in MCPH1 demonstrated a less severe cellular
phenotype and mild microcephaly [5,7]. Later, a muta-
tion in the same gene was identified in patients with
microcephaly disorder, a misregulated chromosomal
condensation termed premature chromosome condensa-
tion (PCC) syndrome and short stature [23,24]. A higher
expression of this gene was observed in the fetal mouse
brain during neurogenesis, especially in ganglionic emi-
nences and lateral ventricles [21]. It was revealed that
both MCPH1 and the PCC syndrome are allelic disor-
ders originating from mutations within the same gene
[4]. This protein is also involved in DNA damage-
induced cellular responses, chromosomal condensation
and during G2/M checkpoint arrest through maintain-
ing the inhibitory cyclin-dependent kinase phosphoryla-
tion [6]. Further studies revealed that the consequences
of MCPH1 deficiency in Drosophila include a slow
mitotic entry, PCC, mitotic entrance with non-replicated
DNA, non-coordinated centrosome, genome instability
and a detached centrosome. Additionally, mitotic arrest
was observed in Drosophila cells with deficient MCPH1
[25,26]. It was also observed that because of the influ-
ence on premature neurogenic formation, the progeni-
tors with reduced MCPH1 increased the production of
early born neurons, which comprise the deep layers
(IV–VI), and decreased the late-born neurons, which
produce the thinner outer cortex layer (II–III). However,
neuronal migration is not affected due to MCPH1 dele-
tion [27]. The successful generation of a mouse model
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for MCPH1-related primary microcephaly revealed
misregulated mitotic chromosome condensation due to
defective MCPH1 function and a reduced skull size
[28,29].
2- WDR62 (MCPH2)
The WDR62 gene is localised inside the MCPH2 locus at
chromosome 19q13.12 and has 32 exons and a genomic
size of 50,230 bp [30]. WDR62 is a WD40 repeat-contain-
ing protein expressed in neuronal precursors and post-
mitotic neurons in the developing brain and is localised in
the spindle poles of dividing cells. Phenotypic variations of
WDR62 advocate its key role in numerous aspects of cere-
bral cortical development [13]; it has been linked with
severe brain malformations. A previous study revealed five
homozygous WDR62 mutations, including deletions and
premature terminations, in patients of Turkish origin suf-
fering from severe brain malformations and microcephaly
[30]. A 7.5 Mb locus on chromosome 19q13.12 composed
of 148 genes was recognised in two families via genome-
wide linkage analysis. Additionally, high throughput
sequencing of associated genes in each family produced
more than 4,000 DNA variants harbouring deleterious
changes involving a single gene WDR62. Additionally, six
mutations were observed in the WDR62 gene through tar-
geted high throughput sequence analysis in six families
suffering from a congenital microcephaly syndrome and
diverse defects in cerebral cortical architecture [13].
Table 1 Summary of known MCPH genes, their location and role.
Locus Gene Cytoband Cellular location Role/effect on brain development References
MCPH1 Microcephalin 8p23.1 Nucleus Involved in chromosomal condensation, reduced MCPH1
enhances the production of early born neurons, which comprise
deep layers (IV–VI), and reduces the late-born neurons, which
produce the thinner outer cortex layer (II–III).
[6,27]
MCPH2 WDR62 19q13.12 Nucleus/Centrosomes/
Neuronal precursors/Post-
mitotic neurons
Cerebral cortical development, proliferation and migration of
neuronal precursors, mutation in WDR62 affects its role in
proliferating and migrating neural precursors and causes severe
brain malformations.
[13,30]
MCPH3 CDK5RAP2 9q33.2 Centrosome Regulates microtubule function, mutation in CDK5RAP2 reduces
the progenitor pool/decreases the number of neurons and
reduces cell survival.
[35,36,38,88]
MCPH4 CASC5 15q15.1 Kinetochore Vital for the spindle checkpoint of the mitotic cycle, CASC5
underscores the role of kinetochore integrity in the proper
volumetric development of the human brain.
[40,41]
MCPH5 ASPM 1q31.3 Pericentrosomal Orientation of mitotic spindles during embryonic neurogenesis,
ASPM mutations can decrease the size of the brain by influencing
the orientation of the mitotic spindle.
[57,54,14]
MCPH6 CENPJ 13q12.12 Centrosome/
neuroepithelium of the
frontal cortex
Controls centriole length/microtubule function, its deletion causes
an increased incidence of multiple spindle poles, apoptosis and
mitosis arrest
[63,64]
MCPH7 STIL 1p33 Pericentrosomal Apoptosis regulator/cell cycle progression, its mutation in
zebrafish causes an embryonic lethal defect, and STIL knockout
mice (Sil-/-) exhibit numerous developmental abnormalities/
decreased size/defective midline neural tube.
[72,69,68]
MCPH8 CEP135 4q12 Centrosome Maintains organisation/structure of the centrosome, CEP135
knockdown showed decreased growth rate/disorganised
microtubules.
[72,70,20]
MCPH9 CEP152 15q21.1 Centrosome Centriole duplication/shape to cell/polarity/motility, conversion of
glutamine into proline disturbs potential coiled-coiled protein
domain/reduced head size.
[76,77]
MCPH10 ZNF335 20q13.12 Nucleus Progenitor cell division/differentiation, mutated ZNF335 gene
causes degeneration of neurons, knockdown of ZNF335 caused a
small brain size with an absent cortex/disrupted proliferation and
differentiation of neuronal cells.
[78]
MCPH11 PHC1 12p13.31 Nucleus Regulates cell cycle, PHC1 mutation highlights the role of
chromatin remodelling in the pathogenesis of Primary
Microcephaly.
[80]
MCPH12 CDK6 7q21.11 Cytoplasmic/nuclear Controls cell cycle/organises microtubules, CDK6 mutation affects
apical neuronal precursor cells proliferation/reduces progenitor
pool/decreases neuronal production/primary microcephaly.
[83]
Abbreviations. MCPH: Autosomal recessive primary microcephaly; MCPH1: Microcephalin; WDR62: WD repeat-containing protein 62; CDK5RAP2: Cyclin dependent
kinase-5 regulatory subunit associated protein; CASC5: Cancer susceptibility candidate-5; ASPM: Abnormal spindle like primary microcephaly; CENPJ: Centromere-
associated protein J; STIL:SCL/TAL1 interrupting locus; CEP135: Centrosomal protein 135; CEP152: Centrosomal protein 152; ZNF335: Zinc Finger Protein 335; PHC1:
Polyhomeotic-like protein 1; CDK6: Cyclin-dependent kinase 6.
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MCPH1 24 8 1 14 1 Iranian (8), Caucasian (1), Pakistani (13) [5,22,51,86,89-91]
WDR62 28 14 1 13 0 Iranian (3), Turkish (11), Mexican (1), Arab (1),
Pakistan (9)
[7,13,30,86,91]
CDKRAP2 6 3 2 1 0 Pakistani (2), Somalian (1) [7,32,34,36,92]
CASC5 1 1 0 0 0 Moroccan (3) [43]
ASPM 104 48 7 48 1 Iranian (13), Arab (12), Indian (8), European (22),
African (5), Pakistani (60), many sporadic cases.
[7,14,50,51,86,91,93]
CENPJ 5 2 1 2 0 Iranian (5), Pakistani (6) [32,60,61,86,91]
STIL 4 2 1 1 0 Iranian (2), Indian (3) [68,86,87]
CEP135 1 0 0 1 0 Pakistani (1) [20]
CEP152 9 5 2 2 0 Pakistani (5), Canadian (3) [77,91,94]
ZNF335 2 1 1 0 0 Arab Israeli (1) [78]
PHC1 1 1 0 0 0 Saudi Arabian (1) [80]
CDK6 1 1 0 0 0 Pakistani (1) [83]
Abbreviations. MCPH: Autosomal recessive primary microcephaly; MCPH1: Microcephalin; WDR62: WD repeat-containing protein 62; CDK5RAP2: Cyclin dependent
kinase-5 regulatory subunit associated protein; CASC5: Cancer susceptibility candidate-5; ASPM: Abnormal spindle like primary microcephaly; CENPJ: Centromere-
associated protein J; STIL:SCL/TAL1 interrupting locus; CEP135:Centrosomal protein 135; CEP152: Centrosomal protein 152; ZNF335: Zinc Finger Protein 335; PHC1:
Polyhomeotic-like protein 1; CDK6: Cyclin-dependent kinase 6.








Premature condensation of chromosome, non-coordinated centrosome, genome instability,
detached centrosome, changes in cell cycle progression and defects in DNA damage repair,
misregulated mitotic chromosome condensation.
[25,26,29]
CDK5RAP2 Cnn-/- (Drosophila) Centrosome dysfunction causes connection loss between centrosomes and pericentriolar matrix.




The Drosophila asp gene is vital for both the organisation and binding together of microtubules
at the spindle poles and to focus the poles of the mitotic spindles during mitosis and meiosis.




Centrioles are lost due to damage of the CENPJ orthologue dsas-4 in Drosophila; in contrast, the
knockout flies can live until adulthood but have weak coordination and lower viability. The
morphological development of mutant flies is normal without cilia or flagella, but they die in
early life.
[65,66]
STIL STIL Sil-/-(mice) STIL knockout mice (Sil-/-) exhibit numerous developmental abnormalities in embryonic days
E7.5-8.5 and die after E10.5, the phenotype of the mutant mice is characterised by decreased
brain size, restricted development, defective midline neural tube, abnormal development, and




In Chlamydomonas, CEP135 ortholog Bld10p mutants (bld10) demonstrated abnormal interphase





CEP152 is the putative mammalian orthologue of Drosophila asterless, mutations in which affect




Knockdown of ZNF335 caused a small brain size with an absent cortex and disrupted the
proliferation and differentiation of neuronal cells. It was observed that knockdown of the ZNF335
ortholog in mice (ZFP335) resulted in early embryonic lethality at day E7.5. Conditional
knockdown of ZNF335 in mouse cortical cells resulted in a small brain with a fundamentally
absent cortex with deficient cortical neurons.
[78]
Abbreviations. MCPH1: Microcephalin; CDK5RAP2: Cyclin dependent kinase-5 regulatory subunit associated protein; ASPM: Abnormal spindle like primary
microcephaly; CENPJ: Centromere-associated protein J; STIL: SCL/TAL1 interrupting locus; CEP135: Centrosomal protein 135; CEP152: Centrosomal protein 152;
ZNF335: Zinc Finger Protein 335.
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Published observations from multiple groups have shown
that WDR62 is mainly nuclear in its location and lacks any
apparent association with the centrosomes. In contrast to
this, other findings have shown that the WDR62 expres-
sion is similar to ASPM, which is also a MCPH protein
focused at the spindle poles in neuronal precursor cells
[30]. Another study further confirmed that disturbance of
the centrosome integrity and spindle defects are the key
players in developing MCPH2 microcephaly [31]. In HeLa
cells, WDR62 accumulates in the centrosome or nucleus
in a cell cycle-dependent manner; siRNA knockdown of
WDR62 in cortical progenitors decreased their prolifera-
tion, caused defective spindle orientation, and reduced the
centrosome integrity, displacement from the spindle poles
and late mitotic development [31].
3- CDK5RAP2 (MCPH3)
Homozygous mutations of cyclin-dependent kinase 5 regu-
latory subunit-associated protein-2 (CDK5RAP2) have been
recognised as the basis of MCPH3 [32]. This protein is
composed of 38 exons encoding 1,893 amino acids. Three
CDK5RAP2 mutations (two in Pakistani families; one in a
Somalian patient) have been described; 1: a nonsense muta-
tion in exon 4 (246T>A); 2: the A to G transition in intron
26 (4005-15A>G) produces a novel splice acceptor site,
frame shift and a premature stop codon; and 3: a nonsense
mutation in exon 8 (700G>T). All of these mutations result
in a truncated protein with CDK5RAP2 functional loss
[32-34]. CDK5RAP2 is strongly linked with the centrosome,
Golgi apparatus, and microtubules and is chiefly present in
the neural progenitors of the ventricular and sub-ventricu-
lar zones of an immature brain; it has also been observed in
glial cells and early born neurons and is progressively down
regulated as the brain matures [35,36]. CDK5RAP2 is also
essential in the regulation of the spindle checkpoint; its loss
causes chromosomal missegregation and decreased spindle
checkpoint protein expression through binding with their
promoters and transcriptional regulation in HeLa cells [37].
A model of the microcephaly phenotype due to a mutation
in CDK5RAP2 causes a premature transition from sym-
metric to asymmetric neuronal progenitor cell division with
a consequent reduction of the progenitor pool, decreased
neurons and reduced cell survival [35,38]. Centrosome dys-
function, which is known as centrosome ‘rocketing’, was
observed within the cells because of the connection loss
between the centrosomes and pericentriolar matrix in the
human CDK5RAP2 ortholog ‘centrosomin’-deficient Droso-
phila embryos (cnn-/-). Only subtle asymmetric division
defects were observed in ‘centrosomin’-deficient Drosophila
embryos (cnn-/-), and the brain sizes were normal [39].
4- CASC5 (MCPH4)
CASC5 is a 265 KDa large protein that belongs to the con-
served KMN protein network and permits chromosomal
kinetochore docking to the microtubule. Its location adja-
cent to the kinetochore remains constant from G2 until
late anaphase; proper docking is very important for suffi-
cient sister chromatid segregation at anaphase and is vital
for the spindle checkpoint of the mitotic cycle [40,41]. A
CASC5 mutation on the MCPH4 locus with an LOD score
of > 6 in MCPH patients from three consanguineous
families has been reported. This mutation enhanced the
skipping of exon 18, produced a frame shift and premature
stop codon in exon 19, followed by truncation of the pre-
dicted protein. Mutation 6125G>A in CASC5 covers the
amino acids from 1,981 to 2,108, which interact with
ZWINT-1, whereas the CASC5 C-terminus is important
for binding with NSL1 and the MIS12 complex in a down-
stream portion of the mutation. Therefore, the loss of
exon 18 and the resulting frame shift and truncation lead
to a functional loss of CASC5[40,42]. This protein is also
upregulated in the ventricular zone of the human fetal
brain and interacts with BUBR1, ZWINT-1 and MIS12
through the N-terminal domain, which can be truncated
due to mutation [43]. A transcriptome analysis through
RNA sequencing of the germinal zone of the human fetal
neocortex at 13-16 gestational weeks revealed a higher
expression of CASC5 in the ventricle zone compared the
sub ventricle zone and cortical plate; this finding further
confirmed the effect of mutated CASC5 on proliferating
cells in the ventricle zone that cause microcephaly [43,44].
Further analysis by CASC5 siRNA knockdown in HeLa
cells revealed chromosomal misalignment and the prema-
ture entry of the cells into mitosis; this defect causes
improper symmetrical and asymmetrical division, which
results in inefficient proliferation, inappropriate neuronal
number and abnormal brain size [45].
5- ASPM (MCPH5)
Abnormal spindle-like primary microcephaly (ASPM),
which is homologous to Drosophila melanogaster, is impor-
tant for the normal functioning of the mitotic spindle in
embryonic neuroblasts harbouring MCPH5 locus [14]. It
consists of 62,567 bp with a 10,906 bp ORF, 28 exons and
3,477 amino acids, with a putative microtubule-interacting
domain at the N-terminus [46,47], calponin homology
domain, 81 isoleucine glutamine motifs acting as a calmo-
dulin binding domain [14,48,49], and a C-terminus without
any identified domains [50]. Studies have revealed four
novel mutations of this gene in 33 families from Pakistan
[51]. ASPM gene mutations truncate the protein and
include deletion, single base pair change, duplication and
variation in the intronic region. Additionally, substantial
numbers of the observed ASPM mutations are compound
heterozygous [10,52]. In neurogenesis, this gene is mainly
expressed in the cerebral cortical ventricular zone and pro-
liferation zones of the medial and lateral ganglion [14].
Another study showed the localisation of this protein at the
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spindles, and its knockdown by siRNA revealed reduced
proliferative symmetric division in the mouse developing
neocortex [53]. Studies have shown that because of neuro-
sphere differentiation, ASPM is downregulated in mice;
additionally, neurosphere proliferation and self-renewal
was decreased as a result of ASPM knockdown [54]. Mor-
pholino-mediated knockdown of ASPM in zebrafish
resulted in a significant reduction in head size [55]. Droso-
phila asp gene mutants were the first to be known as hav-
ing a mini-brain; this asp gene is known to be vital for
both the organisation and binding of microtubules at the
spindle poles and its ability to focus the poles of mitotic
spindles during mitosis and meiosis [56,57]. Additionally,
two mutant mouse lines were generated from gene trap
cells for the study of ASPM function in the development
of the cerebral cortex. The results showed that mutations
in ASPM decreased the size of brain in mice [58]. It is
therefore concluded that ASPM mutations can decrease
the size of the brain by influencing the orientation of the
mitotic spindle and can decrease the neuronal cells by
affecting the asymmetrical to symmetrical cell division
ratios [54,57].
6- CENPJ (MCPH6)
Mutations in the centromere-associated protein J (CENPJ)
gene harboured in the MCPH6 locus on human chromo-
some 13q12.2 have been reported to cause primary micro-
cephaly [32]. This gene is composed of 40,672 bp with a
5,187 bp ORF [46] and 17 exons, which encode a protein
of 1,338 amino acids; it contains 5 coiled-coiled domains,
many protein phosphorylation sites, 21 nonamer G-box
repeats in the C-terminal domain and, C-terminal to that,
contains a leucine zipper motif [32,59]. In total, four
mutations were identified in the CENPJ gene: one muta-
tion in one Brazilian family, [32] and one mutation in two
Pakistani families [32]. Later, another Pakistani family
showed the deletion of four consecutive nucleotides
(TCAG) in the 11th exon of the CENPJ gene, which causes
a frame shift and a premature termination codon 19 bp
downstream in the same exon that is predicted to add six
amino acids downstream of the mutation [60]. The fourth
mutation is a splicing mutation in the CENPJ gene that
was identified in Seckel syndrome patients [61]. This pro-
tein is mainly expressed in the neuroepithelium of the
frontal cortex at the beginning of neurogenesis [32].
Depletion of this protein disturbs the centrosome integrity,
and cells deficient in CENPJ become arrested during
mitosis, with multipolar spindles [62]. An in vitro analysis
showed that this protein can impede microtubule nuclea-
tion and depolymerisation, predicting a role for CENPJ in
directing the centrosomal assembly of microtubules [63].
Prior studies have also shown that CENPJ deletion by
siRNA causes the enhancement of multiple spindle
poles, apoptosis and mitosis arrest [64]. Centrioles are lost
due to damage of the CENPJ orthologue dsas-4 in Dro-
sophila; in contrast, the knockout flies can live until
adulthood but have weak coordination and lower viabi-
lity [65]. The morphological development of mutant
flies is normal without cilia or flagella, but they die in
early life [66]. Sas-4 is a centriole protein controlling
centrosome organisation in C. elegans, and its involve-
ment has been confirmed in the duplication of centro-
some fluorescence recovery after photo bleaching
(FRAP). CENPJ regulates the centriole length through-
out biogenesis, with possible involvement in the accu-
rate recruitment of centriolar microtubules [67].
7- STIL (MCPH7)
The SCL/TAL1 interrupting locus (STIL) gene was identi-
fied at the seventh locus for MCPH, spanning 63,018 bp
with a 5,225 bp ORF, 20 exons and 1,287 residues in a
full-length cytosolic protein of 150 kDa; it also contains a
putative nuclear localisation signal and C-terminal domain
[17,68]. Three mutations causing protein truncation were
observed in members of five Indian families in an 8.39 Mb
region of chromosome 1p33-p32.3 [68]. The expression of
this gene is observed throughout the cytosol but mainly in
the peri-nuclear region, with an essential role in mitotic
entry (G2-M phase), apoptosis regulation and centrosome
function [68]. STIL is a primary response gene that is ubi-
quitously expressed in proliferating cells and in early
embryonic development [69,70]. Studies of zebrafish have
revealed that STIL has an important role in the duplication
of centrosomes and in the organisation of mitotic spindles.
STIL mutation in zebrafish causes an embryonic lethal
defect [69], and STIL knockout mice (Sil-/-) exhibit
numerous developmental abnormalities at embryonic day
E7.5-8.5 and die after E10.5. The phenotype of the mutant
mice is described as a decreased size, restricted develop-
ment, defective midline neural tube, abnormal develop-
ment, enhanced apoptosis, reduced proliferation and
abnormal expression of numerous essential genes, includ-
ing lefty-2 and nodal. Additionally, the observed mutants
were embryonically lethal [71].
8- CEP135 (MCPH8)
Centrosomal protein (CEP135) is encoded by the CEP135
gene, is composed of 26 exons and 1,140 amino acids and
is a conserved a helical protein observed throughout the
cell cycle at the centrosome. As a centrosomal component,
this protein gives more strength to the centrosomes. A
truncated mutation in CEP135 was identified in a Pakis-
tani family at locus 4q12 that caused microcephaly. A
deletion mutation 970delC changes glutamine to serine at
position 324, followed by the premature termination of a
codon. Considering the mutation’s position and the
affected protein; the truncated mutation is definitely not
compatible with the normal function of CEP135[20].
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Studies by electron microscopy revealed that CEP135 is
associated with pericentriolar material, an electron-dense
material around the centrioles. In interphase, the mitotic
spindles are disorganised due to an RNAi-mediated
decreased amount of CEP135 in the cells, which suggests
that CEP135 maintains the organisation and structure of
the centrosomes and microtubules [72]. In Chlamydomo-
nas, CEP135 ortholog bld10p mutants (bld10) demon-
strated abnormal interphase microtubules and mitotic
spindles, defects during cell division and a significant
decrease in the growth rate [73]; additionally, CEP135
knockdown in CHO cells showed a decreased growth
rate [72]. The C-terminal domain of CEP135 contains an
interacting site for its two binding partners, the 50 kDa
dynactin complex subunit (p50) and C-Nap1. Due to the
truncation of CEP135, both p50 and C-Nap1 are released,
promoting the decomposition of centrosomes and the pre-
mature splitting of the centrosomes, respectively [74,75].
9- CEP152 (MCPH9)
CEP152 is an important 152 kDa centrosome protein that
organises the microtubules of animal cells and has an
essential role in giving shape to the cell, polarity, motility
and cell division [76]. The CEP152 gene is localised to the
MCPH4 locus at chromosome 15q21.1; recently, microce-
phaly due to a mutation in the CEP152 gene was desig-
nated as MCPH9 [43,77]. Human CEP152 is an ortholog of
the Drosophila asterless (asl) gene, contains 72,835 bp and
1,710 amino acids encoding a 152 kDa protein [77]. Three
families with one microcephalic child each were identified
from a subpopulation of eastern Canadian. A homozygosity
analysis of two of the families by genome-wide dense SNP
genotyping revealed the locus 15q21.1 chromosome. Exon
sequencing of the candidate genes identified a non-con-
served amino acid conversion into a highly conserved
CEP152 residue [77]. One mutation converts glutamine
into proline, which is anticipated to be pathogenic and can
disturb a potential coiled-coiled protein domain. The other
mutation causes protein truncation by eliminating a por-
tion predicted to be a coding region from the C-terminal
domain [77]. A greater head size reduction was observed in
compound heterozygous females compared with missense
homozygous females. The truncated protein causes a non-
sense-mediated decay of the mutated transcript; studies
have also revealed during a functional assay to observe the
subcellular localisation that the wild type CEP152-GFP
fusion protein can be identified in g-tubulin-co structures
[77]. Mutant CEP152 flagged with GFP failed to colocalize
with the g-tubulin, which further confirmed the pathogeni-
city due to this mutation [77].
10- ZNF335 (MCPH10)
The ZNF335 gene encodes a component of the verte-
brate-specific, trithorax H3K4-methylation chromatin
remodelling complex, which regulates neuronal gene
expression and cell fate [78]. MCPH10 was identified
due to a mutation in the ZNF335 gene in affected mem-
bers of an Arab Israeli family. This mutation was recog-
nised in a homozygous 3332G-A transition in exon
20 of the ZNF335 gene and resulted in an Arg1111 to
His (R1111H) substitution at a conserved residue in the
13th zinc-finger domain. This mutation was identified at
the final position of a splice donor site that disturbed
normal splicing, leading to an abnormally large tran-
script that included introns 19 and 20 with a predicted
premature termination [78]. Patient cells also showed
severely reduced levels of ZNF335 protein, but a few
residual transcripts were identified. Cellular studies
revealed that ZNF335 binds to the chromatin remodel-
ling complex, including H3K4 methyl transferases that
can regulate the expression of specific genes in various
pathways; the complex is analogous to the TrxG
(trithorax) complex in Drosophila. Mutations in nBAF,
one of the neural-specific chromatin regulatory com-
plexes, affected proliferation, revealing that it is related
to microcephaly [79]. Insufficiency of the ZNF335 gene
causes the degeneration of neurons, which makes it
different and much more severe compared with other
microcephaly syndromes that are well linked to postnatal
survival. In vitro and in vivo mouse models showed that
knockdown of ZNF335 caused a small brain size with an
absent cortex and disrupted the proliferation and differen-
tiation of neuronal cells [78]. It was observed that knock-
down of the ZNF335 ortholog in mice (ZFP335) resulted
in early embryonic lethality at day E7.5. Conditional
knockdown of ZNF335 in mouse cortical cells resulted in
a small brain with a fundamentally absent cortex with defi-
cient cortical neurons. Knockdown of ZNF335 in mouse
neuronal progenitor cells caused reduced proliferation and
self-renewal due to premature cell cycle exit. Similar find-
ings were observed in an in vivo embryonic mouse model
using in utero electroporation to target ZNF335 in cortical
progenitor cells. ZNF335 depletion resulted in abnormal
neuronal cell orientation and radial glia with disorganised
dendritic outgrowth. [78].
11- PHC1 (MCPH11)
Primary microcephaly-11 (MCPH11) is caused by homo-
zygous mutation in the PHC1 gene on chromosome
12p13. A 12-year-old girl and her 6-year-old brother, who
were born to related Saudi parents, suffered from primary
microcephaly (-5.8 and -4.3 SD, respectively) and low nor-
mal cognitive function. The brain MRIs were normal,
except for a small brain size. The sister and brother also
had short stature (-3.6 SD and -2.3 SD, respectively) [80].
The mutation, which was found by homozygosity mapping
combined with exome sequencing, segregated with the
disorder and was not found in the dbSNP, Exome Variant
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Server or 1000 Genomes database or in 199 Saudi exomes
or 554 Saudi control individuals [80]. A microarray analysis
showed that various genes with a role in regulating the cell
cycle are dysregulated in the patient cells [80]. Cells with a
PHC1 mutation also enhanced the geminin expression,
which was recapitulated in RNAi experiments in control
and patient cells in which PHC1 was ectopically expressed.
Because geminin has a recognised role in controlling the
cell cycle [81,82], PM pathogenesis could be partly due to
abnormalities in the cell cycle that are the result of accu-
mulated geminin. The patient cells also showed an increase
in DNA damage and defective DNA repair in response to
irradiation and abnormal cell cycle activity consistent with
reduced proliferative activity compared with controls.
These defects were associated with abnormalities in chro-
matin regulation and could be rescued in patient cells by
the overexpression of wild type PHC1[80].
12- CDK6 (MCPH12)
The cyclin-dependent kinase 6 (CDK6) protein controls
the cell cycle and differentiation of different cell types.
Prior studies showed a genetic defect through a novel
MCPH locus on the long arm of chromosome 7
(MCPH12). This mutated gene causes disorganisation of
the microtubules and spindles, distorted nuclei, and super-
numerary centrosomes. Furthermore, this role was con-
firmed by knockdown cells and cells expressing the CDK6
mutant allele, whereas the decreased proliferation
observed in the patient and knockdown cells reinforced its
already described role in controlling the cell cycle [83].
CDK6 mutation also affects apical neuronal precursor cell
proliferation and produces an imbalance between sym-
metric and asymmetric cell division, which results in a
progenitor pool reduction that could be the reason of
decreased neuronal production and, finally primary micro-
cephaly [83]. A study of a consanguineous eight-genera-
tion Pakistani family with ten microcephalic children
showed a new MCPH locus at HSA 7q21.11-q21.3 [83].
Most related candidate genes in this region showed a
homozygous single nucleotide substitution, 589G>A, in
CDK6, which encodes cyclin-dependent kinase 6. This
mutation leads to an abnormal mitotic morphology and
has an effect on cellular localisation because patient pri-
mary fibroblasts failed in recruiting CDK6 to the centro-
some during the mitosis process [84]. This finding was
confirmed by another study that showed a lower prolifera-
tion capacity of CDK6 patient primary fibroblasts and
knockdown cells; CDK6 also has a significant role in dif-
ferentiating various cell types [85].
Mutation spectrum of MCPH Genes in Middle
Eastern and Saudi populations
A total of approximately forty-three families have been
reported with mutations in MCPH gene from the Middle
Eastern and, especially, Saudi Arabian region: twenty-eight
from Iran, fourteen from Arab countries, three from Mor-
occo and one from Saudi Arabia [22,43,80,86,87] . More
specifically, eight Iranian families have been reported with
mutations in the MCPH1 gene, thirteen with mutations in
the ASPM gene, five with mutations in the CENJP gene
and two with mutations in the STIL gene [22,86,87].
CASC5 gene mutation have been found in MCPH patients
from three consanguineous Moroccan families with a
homozygous missense mutation 6125G>A that leads to an
amino acid substitution Met2041Ile; this substitution is
predicted to inactivate an exonic splicing enhancer (ESE),
leading to an abnormal transcript lacking exon 18 [43]. A
total of thirteen Arab families have been reported with
mutations in the ASPM and ZNF335 genes. A homozy-
gous 2974C>T mutation in the PHC1 gene on chromo-
some 12p13 was reported in a 12-year-old girl and her 6-
year-old brother born to related Saudi parents who were
suffering from primary microcephaly [80].
Conclusions
Cognitive capabilities are reduced with a substantial
decrease in brain size in MCPH patients, whose brain
sizes decrease to one third compared with its original
size with a substantial cognitive decline. There are
twelve known genes that cause this neurodevelopmental
disorder, and recent evidence suggests that MCPH is
possibly a primary disorder of neurogenic mitosis. With
the progress of MCPH gene identification, prenatal diag-
nosis (detects a disorder recurrence), postnatal diagnosis
(differentiates the disorder from various differential
diagnosis) and carrier testing (for consanguineous
families in which the disease is known to occur) are
increasingly available for patients. The successful crea-
tion of mammalian models for MCPH has enabled
researchers to further add to the knowledge regarding
the aetiology and pathophysiology of MCPH. Better gen-
otyping, neuro-physiological and neuroimaging testing,
together with the creation of genetically homogeneous
groups of patients, would benefit the identification of
exact genotype phenotype correlations. Mutational
screening in different MCPH families from the Middle
East and especially Saudi Arabia would help in genetic
counselling and prenatal diagnosis for MCPH and
would eventually enable us to reduce the incidence of
MCPH in a highly consanguineous population. Addi-
tionally, these studies have increased our understanding
of the control of neuronal production by neural stem
cells and how this has been modulated by evolution to
control the brain sizes of different species.
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